Association between halo nevi and melanoma in adults: A multicenter retrospective case series - 10/03/21
Doi : 10.1016/j.jaad.2020.08.056
Dylan Haynes, MD, MCR a, Jennifer L. Strunck, BS a, Jordan Said, BA b, Idy Tam, MS c, d, Amir Varedi, MD e, Christina A. Topham, BS a, Brianna Olamiju, BA f, Brian M. Wei, BS f, Maia K. Erickson, BA g, Leo L. Wang, MD, PhD h, Andrea Tan, BS i, Ryan Stoner, PhD a, Rebecca I. Hartman, MD, MPH b, j, k, Evelyn Lilly, MD c, Douglas Grossman, MD, PhD e, l, Julia A. Curtis, MD l, John S. Westerdahl, BS m, Jonathan S. Leventhal, MD f, Jennifer N. Choi, MD g, Emily Y. Chu, MD, PhD h, Michael E. Ming, MD, MSCE h, Jennifer A. Stein, MD, PhD i, Tracey N. Liebman, MD i, Elizabeth Berry, MD a, Teri M. Greiling, MD, PhD a, ⁎ 
a Department of Dermatology, Oregon Health & Science University, Portland
b Harvard Medical School, Boston, Massachusetts
c Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
d Tufts University School of Medicine, Boston, Massachusetts
e Huntsman Cancer Institute, University of Utah, Salt Lake City
f Department of Dermatology, Yale University, New Haven, Connecticut
g Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
h Department of Dermatology, Perelman School of Medicine, Philadelphia, Pennsylvania
i Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York
j Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
k Department of Dermatology, VA Integrated Service Network (VISN-1), Jamaica Plain, Massachusetts
l Department of Dermatology, University of Utah, Salt Lake City
m University of Utah School of Medicine, Salt Lake City
∗Correspondence to: Teri M. Greiling, MD, PhD, 3303 SW Bond Ave, CH16D, Portland, OR 972393303 SW Bond Ave, CH16DPortlandOR97239
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Approved by the Oregon Health & Science University (STUDY00019407). |
© 2020
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 84 - N° 4
P. 1164-1166 - avril 2021 Retour au numéro
Article précédent
- Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months
- Reinhard Dummer, John T. Lear, Alex Guminski, Liang Joo Leow, Nicholas Squittieri, Michael Migden
- Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York City health care system
- Megan H. Trager, Jonathan Lavian, Eunice Y. Lee, Dahsan Gary, Fabian Jenkins, Angela M. Christiano, Lindsey A. Bordone
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?